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Abstract
Background—Sensitivity to mold has been associated with asthma incidence, persistence, and
severity.
Objective—To examine the relationship between skin test reactivity (STR) to molds and
specifically to Alternaria and asthma severity in a group of ethnically diverse children in
Connecticut.
Methods—Demographics and STR to 14 local allergens, including Alternaria, Penicillium, and
mold mix, were obtained for 914 Puerto Rican, African American, and non-Hispanic white
children.
Results—A total of 126 children (14%) had a positive skin test result to mold, and 58 (6%)
demonstrated STR to Alternaria. Compared with non-Hispanic white children, there was no
difference in the likelihood of being sensitized to Alternaria for Puerto Rican and African
American children (odds ratio [OR], 0.7; 95% confidence interval [CI], 0.3–1.5; and OR, 0.9; 95%
CI, 0.4–2.2; respectively). In an adjusted analysis, Alternaria STR was associated with severe,
persistent asthma (OR, 3.4; 95% CI, 1.2–8.6) but did not predict increasing asthma severity. STR
to cat (OR, 2.5; 95% CI, 1.3–4.9) and dog (OR, 2.9; 95% CI, 1.3–6.0) was also associated with
severe persistent asthma. Alternaria STR was associated with severe persistent asthma
independent of the total number of positive skin test results.
Conclusions—Mold and Alternaria STR were uncommon among children in Connecticut.
Alternaria STR was not associated with increasing asthma severity but was associated with severe,
persistent asthma independent of the total number of positive skin test results. There was no
association between ethnicity and Alternaria STR.
INTRODUCTION
Asthma is a significant cause of morbidity and mortality for an estimated 9 million children
in the United States.1,2 The relationship between allergy and asthma in children is well
established.3–6 Among children with asthma, the rate of skin test reactivity (STR) to one or
more allergens has been reported to be as high as 80%.7 One allergen with emerging interest
in its relationship to asthma is the spore-forming saprophyte Alternaria alternata. STR to
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Alternaria has been associated with both the development and persistence of asthma
symptoms.3,7–14 Alternaria STR has also been associated with greater asthma severity, acute
asthma exacerbations, and hospital and intensive care unit (ICU) admissions for asthma in
adults and children,9,15–20 an observation possibly linked to the Alternaria-induced
heightened airway responsiveness reported in children.9,21,22
The relationship between Alternaria STR and ethnicity in children with asthma is
incompletely understood. An increased prevalence of Alternaria STR in children of Hispanic
and African American ethnicities has been reported.21 This result is consistent with
increased prevalence of STR to other commonly tested allergens in minority
children.21,23–27 In Connecticut, Puerto Rican and African American children have both
increased STR to environmental allergens24 and greater asthma severity compared with non-
Hispanic white children.28–31
In this study, we examined the relationship among Alternaria STR, ethnicity, and asthma
severity in a group of 914 ethnically diverse children in Connecticut. In addition, we
investigated the relationship between Alternaria STR and pulmonary function in a subset of
56 children matched by age, sex, and ethnicity with and without Alternaria STR.
METHODS
Study Population
The study population included children with physician-diagnosed asthma who were referred
for allergy skin testing (AST) between June 1, 1998, and December 1, 2007, as part of the
previously described Easy Breathing Program.31,32 All children had current respiratory
symptoms (defined as cough, wheezing, and/or shortness of breath within the previous 12
months). Asthma severity was classified by the child’s physician as intermittent and mild,
moderate, or severe persistent asthma using a validated set of questions33 following the
guidelines of the National Asthma Education and Prevention Program. Surveys were
completed by the parents of participants in Easy Breathing and included questions regarding
demographics (age, ethnicity, sex, insurance), family history of asthma and allergic
symptoms, environmental exposures (environmental tobacco smoke, pets, firewood,
cockroaches, gas stoves, dust), and history of eczema. Ethnicity was self-reported and for
this study is reported as non-Hispanic white, Puerto Rican, or African American.
Spirometry was performed in a subset of the study participants on referral from their
physician. Children with STR to Alternaria were matched to other children without
Alternaria STR on the basis of age, sex, ethnicity, asthma severity, and total number of
positive allergen skin test results. Spirometry testing was conducted using the ndd EasyOne
(Andover, Massachusetts) spirometer. All testing was performed by trained individuals and
followed American Thoracic Society guidelines for quality and reproducibility.34
Spirometry was performed before and 15 to 20 minutes after inhalation of albuterol (180 μg
with spacer). Predicted values for spirometric measures were determined using the Third
National Health and Nutrition Examination Survey values.35
Allergy Skin Testing
AST was performed using the MultiTest device (Lincoln Diagnostics, Decatur, Illinois).
Fourteen common, local allergens were tested, including mold mix (Alternaria, mixed
Aspergillus, Cladosporium sphaerospermum, and mixed Penicillium), Penicillium,
Alternaria, mixed tree pollen, dust mix, mixed grass pollen, mugwort/sage, ragweed,
cockroach (Blattella germanica), dog dander, cat dander, mouse, house dust mite
(Dermatophagoides pteronyssinus and Dermatophagoides farinae), and weed mix (Alk-
Abello, Round Rock, Texas). Histamine and saline solutions were used as positive and
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negative controls, respectively. A result for a specific allergen was considered positive if the
maximum wheal diameter was at least 3 mm after subtraction of the negative control. In this
study, the category of “any mold” includes children who tested positive to at least one of the
individual or die mixed molds included in the AST panel.
Statistical Analyses
Univariate analyses among ordinal and nominal predictors and outcomes were performed
using the Pearson χ2 tests. The Fisher exact test was used when cell sizes were small (<5).
The Student t tests and analysis of variance analyses were used to assess relationships
among continuous variables. Because some categories of data were sparse, we used exact
logistic regression for multivariate models.36,37 This method computes the exact
distributions of sufficient statistics for parameters of interest in a logistic regression model,
conditional on the remaining parameters. The usual asymptotic methods often produce
unreliable results when data are sparse or skewed. However, exact conditional inference
produces valid results in these situations. Asthma severity was examined in 2 ways in
multivariate models. First, severe persistent asthma was compared with asthma of all other
severities. Exact multivariate logistic regression was used to model the relationship between
the variables of interest and severe, persistent asthma (compared with all other severities),
and exact odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Second,
all asthma severities were retained and cumulative logit models were used to examine
whether allergen STR was predictive of increasing asthma severity. Paired t tests were used
to compare pulmonary function data in the subset of matched children. Statistical analyses
were performed using JMP statistical software version 7.0 and SAS version 9.2 Statistical
Software Package (SAS institute Inc. Cary, North Carolina).
RESULTS
Characteristics of the Study Population
Between June 1, 1998, and December 1, 2007, 1, 149 children with physician-confirmed
asthma underwent AST, of whom 914 were younger than 18 years and Puerto Rican,
African American, or non-Hispanic white (Fig 1). Of the 914 children, 66% were Puerto
Rican, 22% were African American, and 12% were non-Hispanic white (Table 1). Puerto
Rican children referred for AST were older, more likely to have Medicaid insurance, and
more likely to have a family history of asthma or allergic disease compared with African
American or non-Hispanic white children. They were also less likely to have a personal
history of eczema than African American children. To address the potential for these
differences to affect later results, age, ethnicity, sex, and personal history of eczema were
included in subsequent multivariate analyses. Seventy percent of referred children had
persistent asthma. There was no difference in asthma severity among Puerto Rican, African
American, and non-Hispanic white children who were referred for AST.
Environmental Exposures
Reported environmental exposures differed among the ethnic groups. Non-Hispanic white
children were less likely than both Puerto Rican and African American children to report
exposure to cockroach (P < .001 and P <.001, respectively) and gas stoves (P < .001 and P
= .04, respectively). They were also more likely than both Puerto Rican and African
American children to report exposure to firewood (P < .001 and P < .001, respectively), cats
(P < .001 and P < .001, respectively), and dogs (P < .001 and P < .001, respectively). There
was no difference in reported exposure to dust (P = .45 and P = .64, respectively). Thirty-
four percent of study participants reported exposure to environmental tobacco smoke, with
no difference among the ethnic groups (P = .43). In univariate analyses, there was no
association between STR to any of the molds in the AST panel and any of the environmental
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exposures studied. For this reason, none of these variables were included in subsequent
multivariate analyses.
AST Reactivity
Sixty-nine percent of children with asthma demonstrated STR to one or more of the tested
allergens (Table 1). Among the children with STR to at least one allergen, the mean (SD)
number of positive skin test results was 3.6 (2.2). There was no difference in the mean
number of positive skin test results among Puerto Rican, African American, and non-
Hispanic white children (P = .27). However, fewer Puerto Rican children (65%) had a
positive skin test result to at least one allergen compared with African American (73%) (P
= .04) and non-Hispanic white children (80%) (P = .002).
Mold STR, Age, and Ethnicity
A total of 126 study participants (14%) had STR to one or more of the molds included in the
AST panel (Table 1). In the univariate analysis (Table 2), there was no association between
Alternaria STR and ethnicity. In contrast, non-Hispanic white children were more likely
than Puerto Rican children to have STR to any mold and more likely than both Puerto Rican
and African American children to have STR to mold mix. Non-Hispanic white children were
also more likely to be sensitized to cat and less likely to be sensitized to cockroach than both
African American and Puerto Rican children. Penicillium STR was more common among
African American children than non-Hispanic white children (P = .004). Dust mite
sensitization was high in all ethnic groups, but there were no differences in rates of
sensitization among Puerto Rican, African American, and non-Hispanic white children.
Children younger than 6 years were more likely to have STR to all of the molds than older
children. In contrast, older children were more likely to have STR to cockroach and dust
mite than children younger than 6 years (Table 2). Children 12 to 18 years of age were also
more likely to have STR to dog. There were no significant differences in STR to cat by age.
Mold STR and Asthma Severity
In the univariate analysis, children with severe, persistent asthma were 3 times as likely to
have STR to Alternaria, cat, and dog and twice as likely to have STR to cockroach
compared with children with intermittent asthma (Table 2).
In multivariate models predicting increased asthma severity and controlling for age,
ethnicity, and personal history of eczema, STR to molds was not predictive of increased
asthma severity. In contrast, STR to cat (P = .01), dog (P = .02), and cockroach (P = .04)
was predictive of increased asthma severity. In other multivariate models that predicted
severe persistent asthma compared with all other severities, however, STR to Alternaria, cat,
and dog was highly associated with severe persistent asthma (Table 3). The total number of
positive skin test results was not associated with either increasing severity (P = .08) or
severe persistent asthma (P = .30).
In a final backward selection model that predicted severe persistent asthma compared with
all other severities and contained STR to Alternaria, cat, and dog, and controlled for age,
sex, ethnicity, and history of eczema, a positive allergen skin test result to cat (OR, 2.3; 95%
CI, 1.2–4.2; P = .009), Alternaria (OR, 2.6; 95% CI, 1.1–6.4; P = .04), and age older than 6
years (P = .01) was predictive of severe persistent asthma, suggesting a contributing role for
each of these factors in severe asthma.
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Pulmonary Function Testing
Spirometry was performed in 167 of the study participants, of whom 32 had a STR to
Alternaria. Of these children with a positive skin test result to Alternaria, 28 were matched
to 28 other children without Alternaria STR on the basis of age, sex, ethnicity, asthma
severity, and total number of positive allergen skin test results (Table 4). There was no
difference in pulmonary function test results for children with asthma and Alternaria STR
compared with children with asthma without Alternaria STR when controlling for the
number of positive AST results, asthma severity, age, sex, and ethnicity.
DISCUSSION
Alternaria alternata is one of the most common airborne fungi in outdoor and indoor
environments. Considered an acroallergen, Alternaria spores are thought to be more
antigenic than pollen because of their smaller size, their high levels, especially in late
summer and after thunderstorms and high winds, and their ability (in mice) to produce
potent TH2 adjuvant effects in the airway.38–40 In this ethnically diverse group of children
with asthma who reside in New England, however, Alternaria STR was not common. The
number of children with Alternaria STR did not vary by ethnicity or age. A positive skin test
result to Alternaria was not associated with increasing asthma severity, although children
with severe persistent asthma were more likely to have a positive skin test result to
Alternaria compared with children with asthma of other severities. This is the first study, to
our knowledge, to demonstrate an association between severe persistent asthma and a
positive skin test result to Alternaria in a minority pediatric population and in a population
that was not selected on the basis of medical services utilization and, in particular, ICU
admission. In contrast, STR to cat, dog, and cockroach was associated with both increased
asthma severity and severe persistent asthma. In a subset of children in whom pulmonary
function testing was available, Alternaria STR was not associated with decreases in
pulmonary function when children were matched for the number of positive AST results.
The number of children with Alternaria STR and severe persistent asthma who underwent
pulmonary function testing was small, and it is possible that such a relationship might have
been missed.
Our low rate of Alternaria STR is in contrast to rates reported by others, ranging from 9.4%
to 46%.3,7,12,21–22,26,41–43 Differences in study demographics and geographic location may
explain these differences and have been demonstrated among inner-city children.21,42 In
warm, dry climates, such as the semiarid climate in Arizona, Alternaria STR in children is
very high,12 whereas considerably lower rates have been found in wet cool climates such as
costal areas.9 Thus, the cool, wet New England climate that favors dust mite growth and
subsequent sensitization may explain our low rates of Alternaria STR in children. Low rates
of Alternaria STR have been reported in individuals with high rates of dust mite
sensitization, as was observed in our study.
Our results suggest that Alternaria STR does not explain the previously reported ethnic
differences in asthma severity,28–30 even though several population studies in adults have
shown that sensitization to Alternaria is associated with an increase risk of having asthma
and with severe episodes of asthma requiring admission to the ICU. An increased risk of
sensitization to indoor and outdoor allergens in Puerto Rican and African American children
with asthma has been demonstrated in other populations, and African American and Puerto
Rican children in this study also demonstrated high rates of sensitization to indoor allergens,
such as cockroach and dust mite but not to mold,8,21,24 suggesting that these are more
important factors in these children.
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Ethnic differences in rates of Alternaria sensitization have been reported in the National
Health and Nutrition Examination Study in which African American children, in contrast to
Mexican American children, had higher odds of sensitivity to Alternaria than white children.
No study, to our knowledge, has reported Alternaria STR rates in Puerto Rican children,
although rates in Hispanics from South America and Mexican Americans were high.12,44
Despite the low overall rate of sensitization to Alternaria, results from this study
demonstrate an association between severe, persistent asthma and Alternaria STR and are
consistent with previous work in both adults16,18,20 and children.9,15 Thus, sensitization to
Alternaria could be a marker for severe persistent asthma as defined by the National Asthma
Education and Prevention Program45 and a risk factor for death or ICU admission.
Alternatively, it may be a marker for increased atopy because sensitization to Alternaria
seldom occurred alone but was often associated with multiple positive skin test results. In a
multivariate model with both Alternaria and total number of positive skin test results,
however, only Alternaria was predictive of severe persistent asthma.
There are several limitations to our study. The small number of positive Alternaria skin test
results and the small number of children in whom spirometry testing was performed may
have made it more difficult to detect potentially significant relationships. It is unlikely that
differences in atopy alone explain this difference because the overall rate of atopy observed
in our study participants is consistent with these other studies. More likely, the low
prevalence of Alternaria STR in this study represents geographic or possibly ethnic
differences in allergen sensitivity among our study population.42 Another limitation of our
study is its cross-sectional design. This design allows us to determine associations among
variables examined but not cause-and-effect relationships. In addition, a selection bias may
exist in regard to children referred for AST. Our referral pattern, however, is consistent with
the demographics of the greater Hartford, Connecticut region. Finally, many allergens,
including Alternaria, show a seasonal pattern of distribution.10,46 It is possible that this
seasonal distribution of Alternaria may have affected AST results.
In summary, STR to mold and Alternaria was not common among children in Connecticut.
In this population, there was no association between ethnicity and Alternaria STR. STR to
Alternaria was associated with severe persistent asthma in a multivariate analysis. Our data
suggest that Alternaria STR is unlikely a major contributor to increasing asthma severity and
ethnic differences in asthma severity in this population but may be a marker for children at
risk for severe, persistent asthma.
Acknowledgments
Funding Sources: This work was supported by grant U18HS11147 from the Agency for Healthcare Research and
Quality (Michelle M. Cloutier, principal investigator) and grant ROI HL68201-A101 from the National, Heart Lung
and Blood Institute (A. David Paltiel, PhD, principal investigator).
We are grateful to the referring physicians who participate in Easy Breathing. We thank Charles B. Hall, PhD for
review of the statistical methods, Autherene Grant for assistance with data management, Catherine Quirk and
Gloria Jones for performing the allergy testing, and Barbara Turgeon for administrative support.
References
1. Dey AN, Bloom B. Summary health statistics for U.S. children: National Health Interview Survey,
2003. Vital Health Stat. 2005; 10(223):1–78.
2. Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics. 1992; 90:657–662.
[PubMed: 1408534]
Lyons et al. Page 6
Ann Allergy Asthma Immunol. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
3. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its association
with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics. 2001;
108:E33. [PubMed: 11483843]
4. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in childhood, I: gender
and allergen related risks for development of hay fever and asthma. Clin Exp Allergy. 1993;
23:941–948. [PubMed: 10779282]
5. Sears MR, Burrows B, Herbison GP, Flannery EM, Holdaway MD. Atopy in childhood. III:
relationship with pulmonary function and airway responsiveness. Clin Exp Allergy. 1993; 23:957–
963. [PubMed: 10779284]
6. Squillace SP, Sporik RB, Rakes G, et al. Sensitization to dust mites as a dominant risk factor for
asthma among adolescents living in central Virginia: multiple regression analysis of a population-
based study. Am J Respir Crit Care Med. 1997; 156:1760–1764. [PubMed: 9412552]
7. Akerman M, Valentine-Maher S, Rao M, et al. Allergen sensitivity and asthma severity at an inner
city asthma center. J Asthma. 2003; 40:55–62. [PubMed: 12699212]
8. Arbes SJ Jr, Gergen PJ, Vaughn B, Zeldin DC. Asthma cases attributable to atopy: results from the
Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2007;
120:1139–1145. [PubMed: 17889931]
9. Downs SH, Mitakakis TZ, Marks GB, et al. Clinical importance of Alternaria exposure in children.
Am J Respir Crit Care Med. 2001; 164:455–459. [PubMed: 11500349]
10. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol. 2004; 113:227–234.
[PubMed: 14767434]
11. Etzel R, Rylander R. Indoor mold and Children’s health. Environ Health Perspect. 1999; 107(suppl
3):463. [PubMed: 10346994]
12. Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for
asthma in children raised in a desert environment. Am J Respir Crit Care Med. 1997; 155:1356–
1361. [PubMed: 9105079]
13. Lopez M, Salvaggio JE. Mold-sensitive asthma. Clin Rev Allergy. 1985; 3:183–196. [PubMed:
3986734]
14. Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ. Importance of house dust mile and
Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of
Australia. Clin Exp Allergy. 1993; 23:812–820. [PubMed: 10780887]
15. Atkinson RW, Strachan DP, Anderson HR, Hajat S, Emberlin J. Temporal associations between
daily counts of fungal spores and asthma exacerbations. Occup Environ Med. 2006; 63:580–590.
[PubMed: 16551756]
16. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening
asthma. Allergy. 2000; 55:501–504. [PubMed: 10843433]
17. O’Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is, common amongst patients
with severe asthma requiring multiple hospital admissions. BMC Pulm Med. 2005; 5:4. [PubMed:
15720706]
18. O’Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible
precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991;
324:359–363. [PubMed: 1987459]
19. Salo PM, Arbes SJ Jr, Sever M, et al. Exposure to Alternaria alternata, in US homes is associated
with asthma symptoms. J Allergy Clin Immunol. 2006; 118:892–898. [PubMed: 17030243]
20. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitisation to airborne
moulds and severity of asthma: cross sectional study from European Community respiratory health
survey. BMJ. 2002; 325:411–414. [PubMed: 12193354]
21. Lester LA, Rich SS, Blumenthal MN, et al. Ethnic differences in asthma and associated
phenotypes: collaborative study on the genetics of asthma. J Allergy Clin Immunol. 2001;
108:357–362. [PubMed: 11544453]
22. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships among
environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial
hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol.
1999; 104 (4 pt 1):775–785. [PubMed: 10518821]
Lyons et al. Page 7
Ann Allergy Asthma Immunol. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
23. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10
common allergens in the US population: results from the third National Health and Nutrition
Examination Survey. J Allergy Clin Immunol. 2005; 116:377–383. [PubMed: 16083793]
24. Celedon JC, Sredl D, Weiss ST, Pisarski M, Wakefield D, Cloutier M. Ethnicity and skin test
reactivity to aeroallergens among asthmatic children in Connecticut. Chest. 2004; 125:85–92.
[PubMed: 14718425]
25. Stevenson MD, Sellins S, Grube E, et al. Aeroallergen sensitization in healthy children: racial and
socioeconomic correlates. J Pediatr. 2007; 151:187–191. [PubMed: 17643776]
26. Stevenson LA, Gergen PJ, Hoover DR, Rosenstreich D, Mannino DM, Matte TD.
Sociodemographic correlates of indoor allergen sensitivity among United States children. J
Allergy Clin Immunol. 2001; 108:747–752. [PubMed: 11692099]
27. Sarpong SB, Hamilton RG, Eggleston PA, Adkinson NF Jr. Socioeconomic status and race as risk
factors for cockroach allergen exposure and sensitization in children with asthma. J Allergy Clin
Immunol. 1996; 97:1393–1401. [PubMed: 8648037]
28. Cohen RT, Celedon JC, Hinckson VJ, et al. Health-care use among Puerto Rican and African-
American children with asthma. Chest. 2006; 130:463–471. [PubMed: 16899846]
29. Higgins PS, Wakefield D, Cloutier MM. Risk factors for asthma and asthma severity in nonurban
children in Connecticut. Chest. 2005; 128:3846–3853. [PubMed: 16354853]
30. Ramsey CD, Celedon JC, Sredl DL, Weiss ST, Cloutier MM. Predictors of disease severity in
children with asthma in Hartford, Connecticut. Pediatr Pulmonol. 2005; 39:268–275. [PubMed:
15668933]
31. Cloutier MM, Wakefield DB, Hall CB, Bailit HL. Childhood asthma in an urban community:
prevalence, care system, and treatment. Chest. 2002; 122:1571–1579. [PubMed: 12426255]
32. Hall CB, Wakefield D, Rowe TM, Carlisle PS, Cloutier MM. Diagnosing pediatric asthma:
validating the Easy Breathing Survey. J Pediatr. 2001; 139:267–272. [PubMed: 11487755]
33. Cowen MK, Wakefield DB, Cloutier MM. Classifying asthma severity: objective versus subjective
measures. J Asthma. 2007; 44:711–715. [PubMed: 17994399]
34. Miller M, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;
26:319–338. [PubMed: 16055882]
35. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general
U.S. population. Am J Respir Crit Care Med. 1999; 159:179–187. [PubMed: 9872837]
36. Cox, DR. The Analysis of Binary Data. New York, NY: Chapman & Hall; 1970.
37. Hirji KF, Mehta CR, Patel MR. Computing distributions for exact logistic regression. J Am Stat
Assoc. 1987; 82:1110–1117.
38. Pulimood TB, Corden JM, Bryden C, Sharpies L, Nasser SM. Epidemic asthma and the role of the
fungal mold Alternaria alternata. J Allergy Clin Immunol. 2007; 120:610–617. [PubMed:
17624415]
39. Marks GY, Bush RK. It’s blowing in the wind: new insights into thunderstorm-related asthma. J
Allergy Clin Immunol. 2007; 120:530–532. [PubMed: 17765752]
40. Kobayashi T, Iijima K, Radhakrishnan S, et al. Asthma-related environmental fungus, Atternaria,
activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol. 2009; 182:2502–
2510. [PubMed: 19201906]
41. Eggleston PA, Rosenstreich D, Lynn H, et al. Relationship of indoor allergen exposure to skin test
sensitivity in inner-city children with asthma. J Allergy Clin Immunol. 1998; 102 (4 pt 1):563–
570. [PubMed: 9802363]
42. Gruchalla RS, Pongracic J, Plaul M, et al. Inner City Asthma Study: relationships among
sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol. 2005; 115:478–485.
[PubMed: 15753892]
43. Kattan M, Mitchell H, Eggleston P, et al. Characteristics of inner-city children with asthma: the
National Cooperative Inner-City Asthma Study. Pediatr Pulmonol. 1997; 24:253–262. [PubMed:
9368259]
44. Soto-Quiros M, Silverman EK, Hanson LA, Weiss ST, Celedon JC. Maternal history, sensitization
to allergens, and current wheezing, rhinitis and eczema among children in Costa Rica. Pediatr
Pulmonol. 2002; 33:237–243. [PubMed: 11921451]
Lyons et al. Page 8
Ann Allergy Asthma Immunol. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
45. National Institutes of Health NH, Lung, and Blood Institute. Guidelines for the Diagnosis and
Management of Asthma: Expert Panel Report 2: Update on Selected Topics 2002. Washington,
DC: National Institutes of Health; 2002. p. 5074Publication 02
46. de Ana SG, Torres-Rodriguez JM, Ramirez EA, Garcia SM, Belmonte-Soler J. Seasonal
distribution of Alternaria, Aspergillus, Cladosporium and Penicillium species isolated in homes of
fungal allergic patients. J Investig Allergol Clin Immunol. 2006; 16:357–363.
Lyons et al. Page 9
Ann Allergy Asthma Immunol. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Flow diagram of study population referred for allergy skin testing.
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